Embecta (EMBC) said Friday it has closed its acquisition of privately held, UK-based medical device maker Owen Mumford.
In March, the companies announced a definitive agreement for Embecta to acquire Owen Mumford for an upfront cash payment of 100 million pounds ($133.6 million), and up to an additional 50 million pounds in performance-based payments based on net sales of the Aidaptus auto-injector platform three years after the closing.